Type 1 diabetes patients to receive 'artificial pancreas' as medication: UK's National Health Service

By Nur Asena Erturk

Type 1 diabetes patients in England will receive an “artificial pancreas” to cope with their condition, the National Health Service announced Tuesday.

The NHS will contact patients this month, including children, to give them the system that regulates glucose levels and insulin delivery for the first time in the world, according to a statement.

“The technology will mean some people with type 1 diabetes will no longer need to inject themselves with insulin but rely on technology to receive this life saving medication,” the NHS explained.

Partha Kar, the NHS national specialty advisor for diabetes, said “this futuristic technology not only improves medical care but also enhances the quality of life for those affected.”

The NHS spends almost £10 billion ($12.55 billion) per year on “identifying and treating diabetes.”